GEODE CAPITAL MANAGEMENT, LLC

Position in SGMT — Sagimet Biosciences Inc.

CIK 1214717 BOSTON, MA

Position in SGMT

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$11,162,266

+$9,545,014 QoQ

Shares Held

1,444,019

+366.5% QoQ

Ownership

2.32%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#13

of 122 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. SGMT ranks #182 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,162,266	1,444,019	+366.5%	Shares	Defined	2026-08-12
2026-03-31	$1,617,252	309,522	+4.6%	Shares	Defined	2026-05-15
2025-12-31	$1,751,466	295,856	+4.5%	Shares	Defined	2026-02-09
2025-09-30	$1,942,840	283,213	+6.7%	Shares	Defined	2025-11-12
2025-06-30	$2,021,768	265,324	+0.6%	Shares	Defined	2025-08-08
2025-03-31	$859,739	263,724	+3.3%	Shares	Defined	2025-05-13
2024-12-31	$1,148,561	255,236	+1.2%	Shares	Defined	2025-02-12
2024-09-30	$698,864	252,298	+56.7%	Shares	Defined	2024-11-12
2024-06-30	$550,797	161,052	-59.7%	Shares	Defined	2024-08-09
2024-03-31	$2,166,910	399,799	+231.0%	Shares	Defined	2024-05-13
2023-12-31	$654,605	120,776	+9.1%	Shares	Defined	2024-02-13
2023-09-30	$974,168	110,701	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.